Rua Life Sciences Share Discussion Threads

[the_real_mr_big] 20/12/2021 16:42

We didn't need to evolve into a large company - the 510k would have provided new cash for more R&D and increased the value of the graft business to be sold off.

Anyway, nice to see some recovery. Has anyone managed a top up in the 60s? I only managed mid 70s.

[semper vigilans] 20/12/2021 13:16

I’m still in but not sure that there will be any more video presentations.

[aykon] 20/12/2021 09:55

I still think that most investors don’t realise that this is essentially an R&D company (and with licensing rights to Elasteon). It is never going to evolve into a major graft company! The way the last update (last week£ has been structured does suggest to me that they have laid the stall to attract buyers for some part(s) of the company. However, this is my personal opinion of how I perceive it.

[aykon] 20/12/2021 09:21

That’s very baa.baa..baar..baric Mr Big!!!

[the_real_mr_big] 20/12/2021 09:10

Yep. Packed onto a trailer, transported all the way up to Aberdeen and f.cked deep and hard.

[bones] 20/12/2021 09:04

Just can’t get away from sheep references on this thread!

[aykon] 20/12/2021 09:00

Looks like a lot of PIs that panic sold have been well and truly fleeced!!

[the_real_mr_big] 20/12/2021 08:54

Being optimistic. Won't happen any time soon.

The only problem with RUA now is the long delay before commercialising grafts. 18 months perhaps? That's too long for many PIs but nothing for IIs, so I'd expect a transfer of stock from PI to II hands.

Looks like the share price chart has got a morning stiffy. Long may it continue.

[cocker] 20/12/2021 07:33

If directors aren't buying at these levels why should we!. Only excuse is in talks to sell something, or is that me being optimistic!

[buywell3] 20/12/2021 02:35

POST REMOVED

[the_real_mr_big] 20/12/2021 00:10

Oh my, he's copypasting charts now.

Could it be that some II wants cheap shares and is paying this schmuck overtime for working on a Sunday?

[buywell3] 19/12/2021 22:31

buywell tries to help as once buywell was helped and appreciated the tutorage by Ashley James no less R.I.P


free stock charts from uk.advfn.com


Short term supports also gone

The Plan needs to be got out there ASAP or as a matter of urgency imo

dyor

[amt] 19/12/2021 22:07

Interesting that Buywell appears on the scene after the share price has collapsed.

[buywell3] 19/12/2021 21:26

POST REMOVED

[buywell3] 19/12/2021 20:54

POST REMOVED

[aykon] 19/12/2021 10:03

Buywell3 you sound like you are not not at all happy with this company and it’s long term strategy! Based on what you are saying surely you must have sold your holding. If that’s the case just move on!

[buywell3] 18/12/2021 22:28

POST REMOVED

[buywell3] 18/12/2021 22:24

POST REMOVED

[bones] 18/12/2021 11:58

Interesting reminder there, 25/10/69. Seems the FDA are happy to plonk an unproven polymer heart valve in some unsuspecting humans yet get funny about the Elasteon coating on a conduit.

Nothing to do with Foldax being American by any chance?

[25october1969] 18/12/2021 10:19

Last comment I can find from Landy is below. Would be good to hear his views on current state of affairs


Landy
Jan '21 - 11:11 - 1197 of 1812
0 5 0
Some observations on the Foldax paper on Life Polymer:
1.The authors are in the main employees of, and consultants or contractors to Foldax and paper sponsored by Foldax without any declaration of interests.
2. Much of this previously published before by the same team.
3.The paper is complementary about ElastEon.
4. Comments of slight superiority to ElastEon 2A but there are many versions of ElastEon that have higher creep resistance, mechanical properties and biostability. (You would expect the team at RUA are making the valve with the most appropriate version of ElastEon for heart valve purposes.)

In short the paper is an advert for clinically unproven Life Polymer but an even better advert for clinically proven ElastEon which has been sustaining life for almost 15 years!

As they say- "imitation is the best form of flattery".

[the_real_mr_big] 18/12/2021 09:23

F.cks sake.
Half of mcap wiped out in 3 days.

Bottom drawer now, as this will take over a year to recover imho.

Can only hope and pray that somebody buys them out on the cheap and takes them out of their misery.

[nimbo10] 17/12/2021 16:58

Really need to step back from the crowd and away from the sell button ask why you invested in first place.

If you had done your research the market cap was undervalued for the ongoing revenue stream with future kickers on the roadmap.

The bigger picture is being missed, as only focus being the recent news. Stand back and let the capitulation take it's course.

There are much riskier/loss making higher cap plays on aim.

Sentiment has been the share price driver lately causing a halfing of market cap.

[bones] 17/12/2021 16:32

Post any graft/HV sales, if they happen, that should kickstart Biomerics to really take their manufacturing contract seriously :)

[aykon] 17/12/2021 16:18

Exactly!! They can then carry on with other R&D projects whilst the work with biometrics continues.

[langland] 17/12/2021 16:01

Agree, Aykon, anyone would think the company doesn't have options despite this week's news. Sell on the patches and grafts and the HV for £3-4 per share and retain the royalty and licensing rights to elasteon.